Smith Group Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Smith Group Asset Management’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,970	Closed	-$124K	–	340
2020 Q2	$124K	Sell	1,970 -30	-2%	-$2.06K	0.01%	185
2020 Q1	$102K	Hold	2,000	–	–	0.01%	213
2019 Q4	$159K	Hold	2,000	–	–	0.01%	215
2019 Q3	$97K	Buy	2,000 +320	+19%	+$16.7K	﹤0.01%	239
2019 Q2	$88K	Hold	1,680	–	–	﹤0.01%	247
2019 Q1	$89K	Sell	1,680 -3,180	-65%	-$156K	﹤0.01%	266
2018 Q4	$200K	Hold	4,860	–	–	0.01%	243
2018 Q3	$185K	Buy	4,860 +200	+4%	+$8.86K	0.01%	252
2018 Q2	$211K	Buy	4,660 +100	+2%	+$4.55K	0.01%	249
2018 Q1	$220K	Buy	+4,560	New	+$254K	0.01%	248

Other funds holding GBT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Smith Group Asset Management's GBT Position: Q3 2020 in Review

Smith Group Asset Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2020, closing a stake of 1,970 shares — an estimated $124K sold.

Smith Group Asset Management first reported a position in GBT in Q1 2018 and held it in 10 quarters. The position peaked at $220K in Q1 2018. 229 funds tracked by Wall St. Rank hold GBT as of Q3 2020.

Smith Group Asset Management reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2020 after selling out during the quarter.
Smith Group Asset Management sold 1,970 Global Blood Therapeutics, Inc. shares in Q3 2020, an estimated $124K.
Smith Group Asset Management first reported a position in Global Blood Therapeutics, Inc. in Q1 2018 and held it in 10 quarters.
Smith Group Asset Management's Global Blood Therapeutics, Inc. position peaked at $220K in Q1 2018.
229 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2020.

Based on Smith Group Asset Management's 13F filing for Q3 2020, filed 4 Nov 2020.